Skip to main content Skip to search Skip to main navigation
 Get a free Melatonin Spray with purchases over €100  Get a free Melatonin Spray with purchases over €100 X
Menu
Premium Nahrungsergänzungsmittel | artgerecht

Soluble ST2: Biomarker for Heart Failure

Soluble ST2 (sST2) is a cardiac biomarker used to assess heart failure severity, prognosis, and cardiovascular risk by measuring a circulating decoy receptor in the blood.

Regular tips about health Regular tips about health
Lexicon Navigation

Things worth knowing about "Soluble ST2"

Soluble ST2 (sST2) is a cardiac biomarker used to assess heart failure severity, prognosis, and cardiovascular risk by measuring a circulating decoy receptor in the blood.

What is Soluble ST2?

Soluble ST2 (abbreviated as sST2) is the circulating, soluble form of the interleukin-1 receptor-like protein ST2. It is a blood-based biomarker primarily used in cardiology to evaluate heart failure and cardiovascular risk. The ST2 protein belongs to the interleukin-1 receptor family and plays a key role in inflammatory signaling and the cardiac response to mechanical stress.

Mechanism of Action

ST2 exists in two main forms: the membrane-bound form (ST2L) and the soluble form (sST2). The natural ligand of ST2L is Interleukin-33 (IL-33), a cytokine that exerts cardioprotective effects by inhibiting cardiac fibrosis and hypertrophy. Soluble ST2 acts as a decoy receptor: it binds IL-33 in the bloodstream before IL-33 can reach and activate the membrane-bound ST2L receptor. This neutralization of IL-33 reduces its cardioprotective effects, thereby promoting adverse cardiac remodeling processes such as myocardial fibrosis and ventricular hypertrophy. Elevated sST2 levels thus reflect ongoing cardiac stress and are associated with worsening heart function.

Clinical Significance and Applications

Heart Failure

The primary clinical application of sST2 is in the assessment of acute and chronic heart failure. Elevated sST2 levels are associated with a poor prognosis, increased hospitalization rates, and higher mortality risk. sST2 complements established heart failure biomarkers such as BNP (B-type natriuretic peptide) and NT-proBNP by providing independent prognostic information.

Myocardial Infarction and Acute Coronary Syndrome

sST2 levels rise following a heart attack and can help identify patients at higher risk for complications or recurrent cardiovascular events, supporting early risk stratification.

Other Areas of Research

Beyond cardiology, sST2 is being investigated in the context of other conditions involving inflammation, including pulmonary diseases, autoimmune disorders, and severe infections such as sepsis.

Diagnosis and Measurement

Soluble ST2 is measured through a standard blood draw. The concentration is determined in serum or plasma using immunological assays such as ELISA. The reference range for healthy adults is typically below 35 ng/mL, with higher values indicating elevated cardiovascular risk. Unlike BNP and NT-proBNP, sST2 is less affected by age, kidney function, and body mass index, which can simplify interpretation in certain patient populations.

Treatment and Clinical Management

Soluble ST2 is not itself a treatment target but serves as a prognostic and diagnostic tool to guide clinical decisions. Elevated sST2 levels may prompt:

  • Intensification of heart failure therapy (e.g., adjustment of ACE inhibitors, beta-blockers, or diuretics)
  • Closer monitoring of high-risk patients
  • Further diagnostic evaluations such as echocardiography or cardiac catheterization

Research suggests that effective heart failure treatment can lead to a reduction in sST2 levels, supporting its role in therapy monitoring and guiding treatment adjustments over time.

References

  1. Januzzi JL Jr. et al. - ST2 as a cardiovascular risk biomarker: from the bench to the bedside. Journal of the American College of Cardiology, 2015. PubMed PMID: 25790876.
  2. Maisel A. et al. - Soluble ST2 for predicting outcomes in patients with acute dyspnea. JACC Heart Failure, 2013. PubMed PMID: 24621876.
  3. Yancy CW et al. - 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology, 2022. DOI: 10.1016/j.jacc.2021.12.012.
artgerecht

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Verwandte Produkte

floral lactoferrin cln mundflora lutschtabletten?ts=1781276101

Average rating of 4.96 out of 5 stars

Floral

For Healthy Oral Flora & Dental Care

Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Sugar free
Lab tested
Non-GMO
Cologne List
Lactose free
Tooth friendly
GMP Quality
Clinical proofed
Pure CLN
30 lozenges
Regular price: €22.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.
lactoferrin 60 eisenbinder transporter kuhmilch?ts=1758111262

Average rating of 4.85 out of 5 stars

Lactoferrin

For your universal protection

As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Lactose free
[siehe Varianten]
Regular price: €59.90
natural iron supplement premium plantderived mineralcomplex?ts=1751927698

Average rating of 4.94 out of 5 stars

Natural Iron

For your iron balance

Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Gluten free
Lactose free
100% vegetarian fermentation
30 Capsules
30 Capsules
Regular price: €35.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.